Sandoz Completes Deal For Mycamine

Acquisition Of Antifungal Brand From Astellas Was Announced In Early 2023

 
• By David Wallace
  
Company sign reading Sandoz A Novartis Division
Sandoz has completed its deal for rights to Mycamine • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business